Episode 67
Biotech Hangout
00:00
Biogen's Layoffs and Executive Changes
Timothy Stanley: There were a lot of companies that hit bumps in the road this week. He says fivergent and reke can turn oh so step down after negative data on their anti-CTG antibodies. Another company, infinity pharmaceuticals has just experienced a breakdown in a merger with any pharma he says. Stanley: You might get the impression again from the news that you know, people are flowing out of this industry. But what's actually going on is companies that are in growth mode.
Transcript
Play full episode
